Cited by 131Cancer-related Molecular PathwaysCell death mechanisms and regulationHeat shock proteins research

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Human and Mouse Fas (APO-1/CD95) Death Receptor Genes Each Contain a p53-responsive Element That Is Activated by p53 Mutants Unable to Induce Apoptosis

Open access

Munsch, Dany, Watanabe-Fukunaga, Rie, Bourdon, Jean-Christophe, Nagata, Shigekasu, May, Evelyne, Yonish-Rouach, Elisheva, Reisdorf, Philippe·2000·Journal of Biological Chemistry

DOI 10.1074/jbc.275.6.3867

Open this paper in CoChat — free account

Abstract

p53 is a tumor suppressor protein that induces apoptosis at least in part through its ability to act as a sequence-specific transactivator. This work reports that intron 1 of the mouse Fas death receptor gene contains a p53-responsive element (p53RE) that matches the p53 consensus sequence and that is located between nucleotides +1704 and +1723 from the transcription initiation site. This element is specifically bound by p53 and functions as a p53-dependent enhancer in mammalian or in yeast reporter gene assays. Contrary to bax, another known pro-apoptotic p53-target gene, both mouse and human FAS p53REs are still activated by the discriminatory p53 mutants Pro-175 and Ala-143, a class of mutants unable to induce apoptosis. We propose that p53-dependent up-regulation of Fas does not induce apoptosis per se but sensitizes the cell to other pro-apoptotic signal(s). The functional conservation of p53-dependent Fas up-regulation argues strongly in favor of its biological importance and suggests that murine models may be used to study further the in vivo role of Fas in the p53 response.

Integrity signals

Registry

Crossref · 10.1074/jbc.275.6.3867

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Transformation of intact yeast cells treated with alkali cations
Ito, H., Fukuda, Y., Murata, K., & Kimura, A. (1983) · Journal of Bacteriology · doi:10.1128/jb.153.1.163-168.1983 · Cited by 7,518
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites
Gietz, R. D., & Sugino, A. (1988) · Gene · doi:10.1016/0378-1119(88)90185-0 · Cited by 2,901
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113

Flagged first, then by citations

Show all 53 references

Research works printed but not linked: 6

Greenblatt, 1994, Cancer Res., 54, 4855
Gottlieb, 1996, Biochim. Biophys. Acta, 1287, 77
Waldman, 1995, Cancer Res., 55, 5187
Fuchs, 1997, Cancer Res., 57, 2550
May, 1989, Oncogene, 4, 1037
Sheikh, 1998, Cancer Res., 58, 1593

Sorted by citations

Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Cellular stress response and apoptosis in cancer therapy
Herr, I., & Debatin, K. (2001) · Blood · doi:10.1182/blood.v98.9.2603 · Cited by 805
Defying death after DNA damage
Rich, T., Allen, R. L., & Wyllie, A. H. (2000) · Nature · doi:10.1038/35037717 · Cited by 724
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 474
Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
Canale, M., Petracci, E., Delmonte, A., Chiadini, E., Dazzi, C., Papi, M., Capelli, L., Casanova, C., De Luigi, N., Mariotti, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0966 · Cited by 288
Apoptosis: biochemical aspects and clinical implications
Kiechle, F. L., & Zhang, X. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00297-8 · Cited by 251
p38α Mitogen-activated Protein Kinase Sensitizes Cells to Apoptosis Induced by Different Stimuli
Porrás, A., Zuluaga, S., Black, E. V. I., Valladares, A., Alvarez, A. M., Ambrosino, C., Benito, M., & Nebreda, Á. R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0592 · Cited by 229
Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice
Bouvard, V., Zaitchouk, T., Vacher, M., Duthu, A., Canivet, M., Choisy, C., Nieruchalski, M., & May, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203366 · Cited by 221
Self-citation
Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence
Inga, A., Storici, F., Darden, T. A., & Resnick, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8612-8625.2002 · Cited by 195
Apoptotic signaling cascades
Ashe, P. C., & Berry, M. D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00016-2 · Cited by 186
Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis
Drane, P., Bravard, A., Bouvard, V., & May, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204101 · Cited by 180
Self-citation
Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells
Zheng, P.-W., Chiang, L., & Lin, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.08.023 · Cited by 173
Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation
Daniely, Y., Dimitrova, D. D., & Borowiec, J. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.6014-6022.2002 · Cited by 174
Drosophila p53 preserves genomic stability by regulating cell death
Sogame, N., Kim, M., & Abrams, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736384100 · Cited by 163
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
Qin, K., Hou, H., Yu, L., & Zhang, X. (2020) · BMC Cancer · doi:10.1186/s12885-020-06805-5 · Cited by 160
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells
Shieh, D., Chen, Y.-Y., Yen, M., Chiang, L., & Lin, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.060 · Cited by 150
Early Growth Response 1 Acts as a Tumor Suppressor In vivo and In vitro via Regulation of p53
Krones‐Herzig, A., Mittal, S., Yule, K., Liang, H., English, C. N., Urcis, R., Soni, T., Adamson, E. D., & Mercola, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3742 · Cited by 136
Fas receptor‐mediated apoptosis: a clinical application?
Timmer, T., de Vries, E. G. E., & de Jong, S. (2001) · The Journal of Pathology · doi:10.1002/path.1028 · Cited by 129
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants
Zalcenstein, A., Stambolsky, P., Weisz, L., Müller, M., Wallach, D., Goncharov, T. M., Krammer, P. H., Rotter, V., & Oren, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206724 · Cited by 123
Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane
Bourdon, J., Renzing, J., Robertson, P., Fernandes, K., & Lane, D. P. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200203006 · Cited by 126
Self-citation
Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence.
Krones-Herzig, A., Adamson, E., & Mercola, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628034100 · Cited by 118
Dinstinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis
Song, Y. S., Lee, B. Y., & Hwang, E. S. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.11.008 · Cited by 120
p53 Enhances Gefitinib-Induced Growth Inhibition and Apoptosis by Regulation of Fas in Non–Small Cell Lung Cancer
Rho, J. K., Choi, Y. J., Ryoo, B., Na, I. I., Yang, S. H., Kim, C. H., & Lee, J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2037 · Cited by 118
Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex
Mohammad, N., Singh, S. V., Malvi, P., Chaube, B., Athavale, D., Vanuopadath, M., Nair, S. S., Nair, B. G., & Bhat, M. K. (2015) · Scientific Reports · doi:10.1038/srep11853 · Cited by 116
Simplified apoptotic cascades
Movassagh, M., & Foo, R. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9070-x · Cited by 106
Regulation of Programmed Cell Death by the P53 Pathway
Kuribayashi, K., & El‐Deiry, W. S. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_10 · Cited by 95
Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively
Porta, C., Hadj-Slimane, R., Nejmeddine, M., Pampin, M., Tovey, M. G., Espert, L., Alvarez, S., & Chelbi‐Alix, M. K. (2004) · Oncogene · doi:10.1038/sj.onc.1208204 · Cited by 97
Epigenetic changes in tumor Fas levels determine immune escape and response to therapy
Maecker, H. L., Yun, Z., Maecker, H. T., & Giaccia, A. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00095-8 · Cited by 93
Fas Is Involved in the p53-Dependent Apoptotic Response to Ionizing Radiation in Mouse Testis1
Embree-Ku, M., Venturini, D. S., & Boekelheide, K. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.5.1456 · Cited by 92
Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma
Peták, I., Danam, R. P., Tillman, D. M., Vernes, R., Howell, S. R., Berczi, L., Kopper, L., Brent, T. P., & Houghton, J. A. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401132 · Cited by 91
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells
Obad, S., Brunnström, H., Vallon-Christersson, J., Borg, Å., Drott, K., & Gullberg, U. (2004) · Oncogene · doi:10.1038/sj.onc.1207524 · Cited by 90
Sustained Activation of p38 Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase Pathways by Hepatitis B Virus X Protein Mediates Apoptosis via Induction of Fas/FasL and Tumor Necrosis Factor (TNF) Receptor 1/TNF-α Expression
Wang, W., Grégori, G., Hullinger, R. L., & ANDRISANI, O. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10352-10365.2004 · Cited by 88
Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review
Guo, Y., Song, J., Wang, Y., Huang, L., Sun, L., Zhao, J., Zhang, S., Jing, W., Ma, J., & Han, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.610923 · Cited by 87
DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis
Olsson, M., Vakifahmetoglu, H., Abruzzo, P. M., Högstrand, K., Grandien, A., & Zhivotovsky, B. (2009) · Oncogene · doi:10.1038/onc.2009.36 · Cited by 83
IFN‐γupregulates apoptosis‐related molecules and enhances Fas‐mediated apoptosis in human cholangiocarcinoma
Ahn, E.-Y. E., Pan, G., Vickers, S. M., & McDonald, J. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10516 · Cited by 83
CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance
Rosenblum, M. D., Olasz, E. B., Woodliff, J. E., Johnson, B. D., Konkol, M. C., Gerber, K. A., Orentas, R. J., Sandford, G. R., & Truitt, R. L. (2003) · Blood · doi:10.1182/blood-2003-09-3184 · Cited by 80
Molecular Abnormalities in Chronic Myeloid Leukemia: Deregulation of Cell Growth and Apoptosis
Bacco, A. D., Keeshan, K., McKenna, S. L., & Cotter, T. G. (2000) · The Oncologist · doi:10.1634/theoncologist.5-5-405 · Cited by 81
Specific Interaction of p53 with Target Binding Sites Is Determined by DNA Conformation and Is Regulated by the C-terminal Domain
Göhler, T., Reimann, M., Cherny, D. I., Walter, K., Warnecke, G., Kim, E. L., & Deppert, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202344200 · Cited by 82
Expression of C-terminal deleted p53 isoforms in neuroblastoma
Goldschneider, D., Horvilleur, E., Plassa, L., Guillaud-Bataille, M., Million, K., Evelyne, W.-D., Danglot, G., de Thé, H., Bénard, J., May, E., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl619 · Cited by 79
Self-citation
Photochemical genotoxicity: principles and test methods
Brendler‐Schwaab, S., Czich, A., Epe, B., Gocke, E., Kaina, B., Müller, L., Pollet, D., & Utesch, D. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(03)00052-8 · Cited by 78
Retention of the Arginine Allele in Codon 72 of the p53 Gene Correlates with Poor Apoptosis in Head and Neck Cancer
Schneider‐Stock, R., Mawrin, C., Motsch, C., Boltze, C., Peters, B., Hartig, R., Buhtz, P., Giers, A., Rohrbeck, A., Freigang, B., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63211-7 · Cited by 76
The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis‐inducing stimuli
Spierings, D. C. J., de Vries, E. G. E., Vellenga, E., & de Jong, S. (2003) · The Journal of Pathology · doi:10.1002/path.1373 · Cited by 72
Effect of p53 Status and STAT1 on Chemotherapy-Induced, Fas-Mediated Apoptosis in Colorectal Cancer
McDermott, U., Longley, D. B., Galligan, L., Allen, W. L., Wilson, T. R., & Johnston, P. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0961 · Cited by 66
p53: 25 years of research and more questions to answer
Bourdon, J., Laurenzi, V. D., Melino, G., & Lane, D. P. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401243 · Cited by 65
Self-citation
Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling
Dunkern, T. R., Wedemeyer, I., Baumgärtner, M., Fritz, G., & Kaina, B. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00185-4 · Cited by 64
Mad dogs, Englishmen and apoptosis: The role of cell death in UV-induced skin cancer
Guzmán, E. A., Langowski, J. L., & Owen‐Schaub, L. B. (2003) · APOPTOSIS · doi:10.1023/a:1024112231953 · Cited by 63
Induction of ROS, p53, p21 in DEHP- and MEHP-exposed LNCaP cells-protection by selenium compounds
Erkekoğlu, P., Rachidi, W., Gürsoy-Yüzügüllü, Ö., Giray, B., Öztürk, M., Favier, A. E., & Hıncal, F. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.001 · Cited by 64
SBDS-deficient cells undergo accelerated apoptosis through the Fas-pathway
Rujkijyanont, P., Watanabe, K., Ambekar, C., Wang, H., Schimmer, A. D., Beyene, J., & Dror, Y. (2008) · Haematologica · doi:10.3324/haematol.11579 · Cited by 59
Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours
di Pietro, A., de Vries, E. G. E., Gietema, J. A., Spierings, D. C. J., & de Jong, S. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.06.014 · Cited by 57
Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB
Lallemand, C., Blanchard, B., Palmieri, M., Lebon, P., May, E., & Tovey, M. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209795 · Cited by 57
Self-citation
Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
Jung, S., Kim, D. H., Choi, Y. J., Kim, S. Y., Park, H., Lee, H., Choi, C., Sung, Y. H., Lee, J. C., & Rho, J. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-99267-z · Cited by 56
The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites
Longley, D. B., Allen, W. L., McDermott, U., Wilson, T. R., Latif, T., Boyer, J. D., Lynch, M., & Johnston, P. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0532 · Cited by 56
Targeting Death Receptors in Bladder, Prostate and Renal Cancer
O’Kane, H. F., Watson, C. J., Johnston, S. R., Peták, I., William, R., Watson, G. W., & Williamson, K. E. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00160-6 · Cited by 51
Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents
Youlyouz‐Marfak, I., Gachard, N., Clorennec, C. L., Najjar, I., Baran‐Marszak, F., Reminieras, L., May, E., Bornkamm, G. W., Fagard, R., & Feuillard, J. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402270 · Cited by 50
Self-citation
Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.
Gurova, K. V., Rokhlin, O. W., Budanov, A. V., Burdelya, L., Chumakov, P. M., Cohen, M. B., & Gudkov, A. V. (2003) · PubMed · Cited by 49
A comprehensive study of p53 transcriptional activity in thymus and spleen of γ irradiated mouse: High sensitivity of genes involved in the two main apoptotic pathways
Alvarez, S., Drané, P., Meiller, A., Bras, M., Chambon, V., Bouvard, V., & May, E. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000600949624 · Cited by 48
Self-citation
TDAG51 Is Not Essential for Fas/CD95 Regulation and Apoptosis In Vivo
Rho, J., Gong, S., Kim, N., & Choi, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8365-8370.2001 · Cited by 47
Breathing new insights into the role of mutant p53 in lung cancer
Chen, T., Ashwood, L. M., Kondrashova, O., Strasser, A., Kelly, G. L., & Sutherland, K. D. (2024) · Oncogene · doi:10.1038/s41388-024-03219-6 · Cited by 47
Ionizing radiation as a response‐enhancing agent for CD95‐mediated apoptosis
Sheard, M. A. (2001) · International Journal of Cancer · doi:10.1002/ijc.1020 · Cited by 42
Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts
Itoh, K., Hase, H., Kojima, H., Saotome, K., Nishioka, K., & Kobata, T. (2003) · Lara D. Veeken · doi:10.1093/rheumatology/keh039 · Cited by 42
Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing
Iwama, E., Sakai, K., Azuma, K., Harada, D., Nosaki, K., Hotta, K., Nishio, M., Kurata, T., Fukuhara, T., Akamatsu, H., et al. (2018) · Cancer Science · doi:10.1111/cas.13820 · Cited by 41
A cross talk between cellular signalling and cellular redox state during heat-induced apoptosis in a rat histiocytoma
Sreedhar, A. S., Pardhasaradhi, B. V. V., Khar, A., & Srinivas, U. K. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00796-1 · Cited by 38
Characterization of p53-mediated Up-regulation of CD95 Gene Expression upon Genotoxic Treatment in Human Breast Tumor Cells
Ruiz‐Ruiz, C., Robledo, G., Cano, E., Redondo, J. M., & López‐Rivas, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304397200 · Cited by 37
Influence of TRP53 Status on FAS Membrane Localization, CFLAR (c-FLIP) Ubiquitinylation, and Sensitivity of GC-2spd (ts) Cells to Undergo FAS-Mediated Apoptosis1
Chandrasekaran, Y., McKee, C. M., Ye, Y., & Richburg, J. H. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.045146 · Cited by 37
Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation
Sémont, A., Nowak, E., Lages, C. S., Mathieu, C., Mouthon, M., May, E., Allemand, I., Millet, P., & Boussin, F. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207821 · Cited by 37
Self-citation
p53-dependent stimulation of redox-related genes in the lymphoid organs of -irradiated mice identification of Haeme-oxygenase 1 as a direct p53 target gene
Meiller, A., Alvarez, S., Drané, P., Lallemand, C., Blanchard, B., Tovey, M. G., & May, E. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm824 · Cited by 41
Self-citation
CD95 Is Part of a Let-7/p53/miR-34 Regulatory Network
Hau, A., Ceppi, P., & Peter, M. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049636 · Cited by 35
Acid Sphingomyelinase Activation Requires Caspase-8 but Not P53 nor Reactive Oxygen Species during Fas-Induced Apoptosis in Human Glioma Cells
Sawada, M., Nakashima, S., Kiyono, T., Yamada, J., Hara, S., Nakagawa, M., Shinoda, J., & Sakai, N. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5437 · Cited by 32
Expression Level of c-FLIP versus Fas Determines Susceptibility to Fas Ligand-Induced Cell Death in Murine Thymoma EL-4 Cells
Kataoka, T., Ito, M., Budd, R. C., Tschopp, J., & Nagai, K. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5438 · Cited by 31
The p53 Protein Influences the Sensitivity of Testicular Germ Cells to Mono-(2-Ethylhexyl) Phthalate-Induced Apoptosis by Increasing the Membrane Levels of Fas and DR5 and Decreasing the Intracellular Amount of c-FLIP1
Chandrasekaran, Y., & Richburg, J. H. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.030858 · Cited by 32
Pigment Epithelial-derived Factor (PEDF)-triggered Lung Cancer Cell Apoptosis Relies on p53 Protein-driven Fas Ligand (Fas-L) Up-regulation and Fas Protein Cell Surface Translocation
Li, L., Yao, Y.-C., Fang, S., Ma, C.-Q., Cen, Y., Xu, Z.-M., Dai, Z., Li, C., Li, S., Zhang, T., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.590000 · Cited by 28
Spatio‐temporal expression of immediate early genes in the central nervous system of SJL/J mice
Gerhauser, I., Alldinger, S., Ulrich, R., & Baumgärtner, W. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.06.004 · Cited by 27
A promoter that acquired p53 responsiveness during primate evolution.
Contente, A., Zischler, H., Einspanier, A., & Dobbelstein, M. (2003) · PubMed · Cited by 24
Two Functionally Divergent p53-responsive Elements in the Rat Bradykinin B2 Receptor Promoter
Marks, J. R., Saifudeen, Z. R., Dipp, S., & El-Dahr, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304543200 · Cited by 24
The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins
Cheema, Z. F., Santillano, D. R., Wade, S. B., Newman, J. M., & Miranda, R. C. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-11 · Cited by 24
p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma
Mergui, X., Puiffe, M., Valteau‐Couanet, D., Lipinski, M., Bénard, J., & Amor-Guéret, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-473 · Cited by 23
The prognostic impact of TP53 comutation in EGFR mutant lung cancer patients: a systematic review and meta-analysis
Zhang, R., Tian, P., Chen, B., Wang, T., & Li, W. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1585690 · Cited by 23
Targeting Hepatoma Using Nitric Oxide Donor Strategies
González, R., Ferrín, G., Aguilar‐Melero, P., Ranchal, I., Linares, C. I., Bello, R. I., de la Mata, M., Gogvadze, V. G., Bárcena, J. A., Álamo-Martínez, J. M., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4476 · Cited by 22
Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer
Boldrini, L., Faviana, P., Pistolesi, F., Gisfredi, S., Quirico, D. D., Lucchi, M., Mussi, A., Angeletti, C. A., Baldinotti, F., Fogli, A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204727 · Cited by 22
Regulating the genome surveillance system: miRNAs and the p53 super family
Bailey, S. G., Sánchez-Elsner, T., Stephanou, A., Cragg, M. S., & Townsend, P. A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0456-1 · Cited by 22
Essential role of p53 in trophoblastic apoptosis induced in the developing rodent placenta by treatment with a DNA-damaging agent
Yamauchi, H., Katayama, K., Ueno, M., He, X. J., Mikami, T., Uetsuka, K., Doi, K., & Nakayama, H. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0099-z · Cited by 21
Fas/CD95-mediated apoptosis in human glioblastoma cells: a target for sensitisation to topoisomerase I inhibitors
Ciusani, E., Perego, P., Carenini, N., Corna, E., Facchinetti, F., Boiardi, A., Salmaggi, A., & Zunino, F. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00837-1 · Cited by 20
Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma1
Mahidhara, R. S., de Oliveira, P. E. Q., Kohout, J., Beer, D. G., Lin, J., Watkins, S. C., Robbins, P. D., & Hughes, S. J. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.08.016 · Cited by 19
Correlation between antioxidant status, tumorigenicity and radiosensitivity in sister rat cell lines
Bravard, A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.705 · Cited by 19
Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation
Brune, M., Müller, M., Melino, G., Bierhaus, A., Schilling, T., & Nawroth, P. P. (2012) · Oncogene · doi:10.1038/onc.2012.150 · Cited by 20
The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells
Goldschneider, D., Million, K., Meiller, A., Haddada, H., Puisieux, A., Bénard, J., May, E., & Douc‐Rasy, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.01704 · Cited by 18
Self-citation
Replication of damaged DNA in vitro is blocked by p53
Zhou, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg468 · Cited by 18
Accumulation of an inactive form of p53 protein in cells treated with TNFα
Drané, P., Leblanc, V., Miró‐Mur, F., Saffroy, R., Debuire, B., & May, E. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400983 · Cited by 20
Self-citation
A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions
Inga, A., Nahari, D., Velasco-Miguel, S., Friedberg, E. C., & Resnick, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205779 · Cited by 17
The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
Fregni, M., Ciribilli, Y., & Zawacka‐Pankau, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137213 · Cited by 16
The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos
Husseini, N. E., & Hales, B. F. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx270 · Cited by 13
CD95L/FasL and its receptor CD95 (APO-1/Fas)
Peter, M. E., Barnhart, B. C., & Algeciras-Schimnich, A. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50042-9 · Cited by 15
Tissue Microarray Analysis of Fas and FasL Expressions in Human Non-small Cell Lung Carcinomas; with Reference to the p53 and bcl-2 Overexpressions
Myong, N. (2005) · Journal of Korean Medical Science · doi:10.3346/jkms.2005.20.5.770 · Cited by 12
Mutations of Fas (APO-1/CD95) and p53 Genes in Nonmelanoma Skin Cancer
Boldrini, L., Loggini, B., Gisfredi, S., Zucconi, Y., Baldinotti, F., Fogli, A., Simi, P., Cervadoro, G., Barachini, P., Basolo, F., et al. (2003) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-002-0105-6 · Cited by 12
Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report
Colombo, C., Pogliaghi, G., Tosi, D., Muzza, M., Bulfamante, G., Persani, L., Fugazzola, L., & Cirello, V. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.949098 · Cited by 11
APOPTOTIC PROTEINS
McCarthy, N. J., Mercer, J. R., & Bennett, M. R. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70196-x · Cited by 8
Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
Yi, Y., Pyun, S.-H., Kim, C., Yun, G., Kang, E., Heo, S., Ullah, I., & Lee, S. (2024) · Cells · doi:10.3390/cells13060548 · Cited by 7
Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.
Li, Y., Xu, K., Jiang, D., Zhao, J., Ge, J.-F., & Zheng, S.-Y. (2015) · PubMed Central · Cited by 7
Inhibition of MAT2A Impairs Skeletal Muscle Repair Function
Xiao, W., Huang, T.-E., Zhou, J., Wang, B., Wang, X., Zeng, W., Wang, Q., Lan, X., & Xiang, Y. (2024) · Biomolecules · doi:10.3390/biom14091098 · Cited by 6

Authors: Munsch, D., Watanabe-Fukunaga, R., Bourdon, J.-C., Nagata, S., May, E., Yonish-Rouach, E., & Reisdorf, P.
Affiliations: Centre National de la Recherche Scientifique (FR)
The University of Osaka (JP)
Corresponding author: Reisdorf, Philippe
ORCID: Bourdon, Jean-Christophe
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2000-02
Volume: 275
Issue: 6
Pages: 3867-3872
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.275.6.3867
OpenAlex: W2022923458
Cited by: 131
References: 53
Citations by year: 2025: 1 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 14 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 2 · 2012: 3
FWCI: 6.92
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 7554 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: Fas, p53 response elements, p53, intron 1, mutant p53, apoptosis sensitization, Bax, tumor suppressor
MeSH terms: Animals, Cell Line, Humans, Mutation, Promoter Regions, Genetic, Protein Binding, Transfection, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Genes, Reporter, fas Receptor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human and Mouse Fas (APO-1/CD95) Death Receptor Genes Each Contain a p53-responsive Element That Is Activated by p53 Mutants Unable to Induce Apoptosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks